Literature DB >> 2595267

Topical treatment of ulcerative proctitis with lidocaine.

S Björck1, A Dahlström, H Ahlman.   

Abstract

Rectal biopsy specimens from patients with ulcerative proctitis/proctosigmoiditis (UP/PS) were investigated immunocytochemically. In general, a changed mucosal innervation was demonstrated, with a marked increase in the number of nerve fibres and terminals with neuropeptide Y and tyrosine hydroxylase. In a few patients a hyperinnervation with VIPergic or SPergic nerves was seen. These findings indicate that hyperactive local nervous reflexes are of pathogenetic importance. To silence such activity, the diseased mucosa was treated with topically applied lidocaine. Such topical treatment with lidocaine gel in 21 consecutive patients with UP/PS for 3-8 weeks caused a rapid decrease of subjective and objective symptoms. During treatment mucosal integrity was restored, accompanied by depletion of OKT4 and OKT8 lymphocytes from the mucosa. However, the hyperinnervation pattern persisted during treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2595267     DOI: 10.3109/00365528909089256

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

Review 1.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

2.  Anti-inflammatory efficiency of levobupivacaine in an experimental colitis model.

Authors:  Ugur Duman; Aysun Yilmazlar; Ersin Ozturk; Sibel Aker; Emre Sarandol; Tuncay Yilmazlar
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

Review 3.  Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation.

Authors:  Ashkan Farhadi; Jeremy-Z Fields; Ali Keshavarzian
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

4.  Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: a prospective study report.

Authors:  K Makiyama; F Takeshima; T Hamamoto
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

5.  Neuroendocrine changes in colon of mice with a disrupted IL-2 gene.

Authors:  B F Qian; M El-Salhy; S Melgar; M L Hammarström; A Danielsson
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

6.  Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis.

Authors:  Inge Depoortere; Theo Thijs; Theo L Peeters
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats.

Authors:  S Björck; E Jennische; A Dahlström; H Ahlman
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

Review 8.  How important is onset of action in ulcerative colitis therapy?

Authors:  Steven Masson; David Nylander; John C Mansfield
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability.

Authors:  Eva Arlander; Jan Sjövall; Jörgen Sörstad; Carina Norsten-Höög; Lars L Gustafsson
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

10.  Ropivacaine and lidocaine inhibit proliferation of non-transformed cultured adult human fibroblasts, endothelial cells and keratinocytes.

Authors:  T Martinsson; A Haegerstrand; C J Dalsgaard
Journal:  Agents Actions       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.